CLINICAL_TRIALS
trial_result
· 2019-12-06
Clinical Trial Update: Spondylitis Trial of Apremilast for Better Rheumatic Therapy [Phase 2]
Summary
Phase 2 clinical trial update for apremilast in ankylosing spondylitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-06